Free Family Medicine CME

In this MedX activity, Michael Blaha, MD, explores the evolving landscape of low-density lipoprotein cholesterol (LDL-C) management in patients with atherosclerotic cardiovascular disease (ASCVD), with a focus on the current role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and how emerging novel PCSK9 inhibitor formulations may be integrated into clinical practice as they become available.

Listening First: Shared Decisions That Build Trust in Pediatric Obesity Care is a CME activity designed to support pediatricians in delivering effective, evidence-based care to children and adolescents with obesity. Despite the growing prevalence and risks of pediatric obesity, many clinicians face barriers such as limited training, low confidence, and discomfort initiating sensitive conversations.

This activity provides practical guidance on guideline-recommended screening, culturally and developmentally appropriate communication strategies, and the development of individualized treatment plans. With a focus on shared decision-making and building trust with families, participants will gain the tools needed to improve patient engagement and outcomes in pediatric obesity care.

Meet a 52-year-old woman with type 2 diabetes and hypertension whose recent laboratory results reveal a decline in kidney function. How would you manage this patient? In this 15-minute activity, read about next steps in the management of advanced kidney disease.